Literature DB >> 26454272

Rho-modifying bacterial protein toxins.

Klaus Aktories1.   

Abstract

Rho proteins are targets of numerous bacterial protein toxins, which manipulate the GTP-binding proteins by covalent modifications, including ADP ribosylation, glycosylation, adenylylation, proteolytic cleavage and deamidation. Bacterial toxins are important virulence factors but are also potent and efficient pharmacological tools to study the physiological functions of their eukaryotic targets. Recent studies indicate that amazing variations exist in the molecular mechanisms by which toxins attack Rho proteins, which are discussed here. © FEMS 2015. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  ADP ribosylation; AMPylation; Rho protein; bacterial protein toxins; deamidation; glycosylation

Mesh:

Substances:

Year:  2015        PMID: 26454272     DOI: 10.1093/femspd/ftv091

Source DB:  PubMed          Journal:  Pathog Dis        ISSN: 2049-632X            Impact factor:   3.166


  10 in total

1.  RHOA activity in expanding blastocysts is essential to regulate HIPPO-YAP signaling and to maintain the trophectoderm-specific gene expression program in a ROCK/actin filament-independent manner.

Authors:  Yusuke Marikawa; Vernadeth B Alarcon
Journal:  Mol Hum Reprod       Date:  2019-02-01       Impact factor: 4.025

2.  ROCK and RHO Playlist for Preimplantation Development: Streaming to HIPPO Pathway and Apicobasal Polarity in the First Cell Differentiation.

Authors:  Vernadeth B Alarcon; Yusuke Marikawa
Journal:  Adv Anat Embryol Cell Biol       Date:  2018       Impact factor: 1.231

3.  Characterization of Pyrin Dephosphorylation and Inflammasome Activation in Macrophages as Triggered by the Yersinia Effectors YopE and YopT.

Authors:  Natasha P Medici; Maheen Rashid; James B Bliska
Journal:  Infect Immun       Date:  2019-02-21       Impact factor: 3.441

Review 4.  Targeting ADP-ribosylation as an antimicrobial strategy.

Authors:  Giuliana Catara; Annunziata Corteggio; Carmen Valente; Giovanna Grimaldi; Luca Palazzo
Journal:  Biochem Pharmacol       Date:  2019-06-06       Impact factor: 5.858

5.  Bartonella effector protein C mediates actin stress fiber formation via recruitment of GEF-H1 to the plasma membrane.

Authors:  Simon Marlaire; Christoph Dehio
Journal:  PLoS Pathog       Date:  2021-01-28       Impact factor: 6.823

6.  Structural basis for selective AMPylation of Rac-subfamily GTPases by Bartonella effector protein 1 (Bep1).

Authors:  Nikolaus Dietz; Markus Huber; Isabel Sorg; Arnaud Goepfert; Alexander Harms; Tilman Schirmer; Christoph Dehio
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-23       Impact factor: 12.779

7.  Optineurin links Hace1-dependent Rac ubiquitylation to integrin-mediated mechanotransduction to control bacterial invasion and cell division.

Authors:  Serena Petracchini; Daniel Hamaoui; Anne Doye; Atef Asnacios; Florian Fage; Elisa Vitiello; Martial Balland; Sebastien Janel; Frank Lafont; Mukund Gupta; Benoit Ladoux; Jerôme Gilleron; Teresa M Maia; Francis Impens; Laurent Gagnoux-Palacios; Mads Daugaard; Poul H Sorensen; Emmanuel Lemichez; Amel Mettouchi
Journal:  Nat Commun       Date:  2022-10-13       Impact factor: 17.694

8.  Type VI secretion system MIX-effectors carry both antibacterial and anti-eukaryotic activities.

Authors:  Ann Ray; Nika Schwartz; Marcela de Souza Santos; Junmei Zhang; Kim Orth; Dor Salomon
Journal:  EMBO Rep       Date:  2017-09-14       Impact factor: 8.807

9.  Enteropathogenic Escherichia coli EspH-Mediated Rho GTPase Inhibition Results in Desmosomal Perturbations.

Authors:  Jennifer Lising Roxas; Ross Calvin Monasky; Bryan Angelo P Roxas; Al B Agellon; Asad Mansoor; James B Kaper; Gayatri Vedantam; V K Viswanathan
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2018-04-27

10.  MS-Based in Situ Proteomics Reveals AMPylation of Host Proteins during Bacterial Infection.

Authors:  Theresa Rauh; Sophie Brameyer; Pavel Kielkowski; Kirsten Jung; Stephan A Sieber
Journal:  ACS Infect Dis       Date:  2020-12-01       Impact factor: 5.578

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.